Notice2021-21180
Notice of Product Exclusion Extensions: China's Acts, Policies, and Practices Related to Technology Transfer, Intellectual Property, and Innovation
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
September 29, 2021
Issuing agencies
Trade Representative, Office of United States
Abstract
In prior notices, the U.S. Trade Representative modified the action in the Section 301 investigation of China's acts, policies, and practices related to technology transfer, intellectual property, and innovation by excluding from additional duties certain medical-care products needed to address the COVID-19 pandemic. These exclusions are scheduled to expire on September 30, 2021. On August 27, 2021, USTR requested comments on whether to extend these exclusions for up to six months. This notice announces the U.S. Trade Representative's determination to adopt an interim extension of these exclusions for 45 days in order to provide time to review the public comments.
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 186 (Wednesday, September 29, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 186 (Wednesday, September 29, 2021)]
[Notices]
[Page 54011]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-21180]
=======================================================================
-----------------------------------------------------------------------
OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE
Notice of Product Exclusion Extensions: China's Acts, Policies,
and Practices Related to Technology Transfer, Intellectual Property,
and Innovation
AGENCY: Office of the United States Trade Representative (USTR).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In prior notices, the U.S. Trade Representative modified the
action in the Section 301 investigation of China's acts, policies, and
practices related to technology transfer, intellectual property, and
innovation by excluding from additional duties certain medical-care
products needed to address the COVID-19 pandemic. These exclusions are
scheduled to expire on September 30, 2021. On August 27, 2021, USTR
requested comments on whether to extend these exclusions for up to six
months. This notice announces the U.S. Trade Representative's
determination to adopt an interim extension of these exclusions for 45
days in order to provide time to review the public comments.
DATES: The extensions announced in this notice will extend the product
exclusions through November 14, 2021.
FOR FURTHER INFORMATION CONTACT: For general questions about this
notice, contact Associate General Counsel Philip Butler or Assistant
General Counsel David Salkeld at (202) 395-5725. For specific questions
on customs classification or implementation of the product exclusions,
contact <a href="/cdn-cgi/l/email-protection#3d494f5c59584f58505859447d5e5f4d1359554e135a524b"><span class="__cf_email__" data-cfemail="2a5e584b4e4f584f474f4e536a49485a044e4259044d455c">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION:
A. Background
On December 29, 2020, USTR announced the extension of 80 product
exclusions on medical-care and/or COVID response products; further
modifications in the form of 19 product exclusions, to remove Section
301 duties from additional medical-care and/or COVID response products;
and that USTR might consider further extensions and/or modifications as
appropriate. See 85 FR 85831 (the December 29 notice). On March 10,
2021, USTR announced the extension of these 99 exclusions until
September 30, 2021, and that USTR might consider further extensions
and/or modifications as appropriate. 86 FR 13785 (the March 10 notice).
On August 27, 2021, USTR published a Federal Register notice
requesting public comments on whether any of these 99 exclusions should
be further extended for up to six months. 86 FR 48280 (the August 27
notice). Pursuant to that notice, USTR will collect comments through
its comment portal until September 27, 2021.
B. Interim Extension of COVID Exclusions
To provide time for USTR to review the comments it receives in
response to the August 27 notice, the U.S. Trade Representative has
determined to adopt an interim extension of these exclusions for 45
days. Accordingly, pursuant to sections 301(b), 301(c), and 307(a) of
the Trade Act of 1974, as amended, the U.S. Trade Representative has
determined to extend the 99 product exclusions described in the
December 29 and March 10 notices through November 14, 2021. This change
is described in the Annex to this notice. The U.S. Trade
Representative's decision to adopt an interim extension considers
public comments previously provided, as well as advice of advisory
committees and the interagency Section 301 Committee.
As provided in the December 29 and March 10 notices, the exclusions
are available for any product that meets the description in the product
exclusion. The U.S. Trade Representative may continue to consider
further extensions and/or additional modifications as appropriate. U.S.
Customs and Border Protection will issue instructions on entry guidance
and implementation.
Annex
Effective with respect to goods entered for consumption, or
withdrawn from warehouse for consumption, on or after 12:01 a.m.
eastern daylight time on October 1, 2021, and before 11:59 p.m.
eastern standard time on November 14, 2021, each of the article
descriptions of headings 9903.88.62, 9903.88.63, 9903.88.64 and
9903.88.65 of the Harmonized Tariff Schedule of the United States
are modified by deleting ``September 30, 2021,'' and by inserting
``November 14, 2021,'' in lieu thereof.
Greta Peisch,
General Counsel, Office of the United States Trade Representative.
[FR Doc. 2021-21180 Filed 9-28-21; 8:45 am]
BILLING CODE 3290-F1-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on September 29, 2021.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.